CNS

U.S. Specialty Injectable Generics Market Analysis 2014-2017 & 2025 – Focus on Oncology, Cardiovascular, Central Nervous System, Infectious Diseases, Autoimmune Disorders – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “U.S. Specialty Injectable Generics Market Analysis By Therapeutic Use (Oncology, Cardiovascular, Central Nervous System, Infectious Diseases, Autoimmune Disorders), And Segment Forecasts, 2014 – 2025” report has been added to ResearchAndMarkets.com’s offering.

“U.S. Specialty Injectable Generics Market Analysis By Therapeutic Use (Oncology, Cardiovascular, Central Nervous System, Infectious Diseases, Autoimmune Disorders), And Segment Forecasts, 2014 – 2025”

Tweet this

The U.S. specialty injectable generics market is expected to reach USD 27.8 billion by 2025

High demand for cost-effective drugs for the treatment of cancer, autoimmune diseases, hepatitis, and infectious diseases is expected to create huge opportunities for manufacturers of specialty injectable generics. This has also encouraged many insurance companies to provide reimbursement for these products due to their low cost. According to FDA, generic drugs cost 80% to 85% lesser than branded drugs.

The affordability of these products can be attributed to elimination…